Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

Crystalys Therapeutics has announced the appointment of Justin Thacker as Chief Financial Officer (CFO). Thacker has spent over 20 years in leadership roles across the life sciences industry. He was most recently CFO of Capstan Therapeutics, during which time he assisted in the $2.1bn acquisition of the company by AbbVie. He also held the role […] The post Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer appeared first on Pharmafile.

Continue reading →